TABLE 3.
Cancer type | Tumor cell-intrinsic PD-1 function | Mechanism | References |
---|---|---|---|
Melanoma | PD-1 promoted tumor growth | PD-1 increased the level of phosphorylation of S6, mTOR components, and eIF4E | Kleffel et al. (2015), Schatton et al. (2010) |
Hepatoma | PD-1 increased the level of phosphorylation of S6, mTOR components, and eIF4E | Li et al. (2017) | |
Pancreatic cancer | PD-1 activated the hippo pathway and increased the expression of CYR61 and CTGF. | Pu et al. (2019) | |
NSCLC | PD-1 inhibited tumor growth | Mechanism was not specified | Du et al. (2018) |
Lung cancer | PD-1 inhibited the activation of AKT and ERK signaling | Wang et al. (2020c) |
mTOR, mammalian target of rapamycin; eIF4E, eukaryotic initiation factor 4E; CYR61, cysteine-rich angiogenic inducer 61; CTGF, connective tissue growth factor; NSCLC, non-small-cell lung carcinoma; ERK, extracellular signal-regulated kinase.